Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Disorders of Glycosylation”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableStudy completedNCT04198987
What this trial is testing

Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation

Who this might be right for
Congenital Disorder of Glycosylation
Mayo Clinic 20
Not applicableUnknownNCT02503267
What this trial is testing

"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"

Who this might be right for
Congenital Heart DiseasesConotruncal DefectsCongenital Disorder of Glycosylation+1 more
Hospital Universitari Vall d'Hebron Research Institute 300
Testing effectiveness (Phase 2)UnknownNCT03404869
What this trial is testing

Study of ORL-1M (D-mannose) in Patients With CDG-Ib

Who this might be right for
CDG Ib
Orpha Labs 5
Large-scale testing (Phase 3)Ended earlyNCT04679389
What this trial is testing

Acetazolamide Efficacy in Ataxia in PMM2-CDG

Who this might be right for
Pmm2-CDGCDG1A
Mayo Clinic 25
Testing effectiveness (Phase 2)Study completedNCT03354533
What this trial is testing

Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II

Who this might be right for
Leukocyte Adhesion Deficiency, Type II
Orpha Labs 4
Not applicableUnknownNCT04833322
What this trial is testing

Galactose Supplementation for the Treatment of MOGHE

Who this might be right for
Refractory EpilepsySLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation
Hospital Ruber Internacional 8
Not applicableStudy completedNCT03560570
What this trial is testing

Study of Hemostasis in Patients With Congenital Disorder of Glycosylation

Who this might be right for
Congenital Disorders of Glycosylation
Assistance Publique - Hôpitaux de Paris 57
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableStudy completedNCT03250728
What this trial is testing

Role of the Endothelium in Stroke-like Episode Among CDG Patients

Who this might be right for
Congenital Disorders of Glycosylation
Assistance Publique - Hôpitaux de Paris 6
Not applicableLooking for participantsNCT02089789
What this trial is testing

Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation

Who this might be right for
Congenital Disorders of Glycosylation
National Human Genome Research Institute (NHGRI) 200
Not applicableLooking for participantsNCT04199000
What this trial is testing

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Who this might be right for
Congenital Disorders of Glycosylation
Icahn School of Medicine at Mount Sinai 500
Not applicableStudy completedNCT04201067
What this trial is testing

Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism

Who this might be right for
Congenital Disorders of Glycosylation
Mayo Clinic 240
Not applicableStudy completedNCT03173300
What this trial is testing

Natural History Study Protocol in PMM2-CDG (CDG-Ia)

Who this might be right for
Phosphomannomutase 2 Deficiency
Glycomine, Inc. 139
Post-approval studies (Phase 4)UnknownNCT01184599
What this trial is testing

A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAHypertension
Kagawa University 30
Testing effectiveness (Phase 2)Study completedNCT05549219
What this trial is testing

24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG

Who this might be right for
Pmm2-CDGPhosphomannomutase 2 Deficiency
Glycomine, Inc. 27
Large-scale testing (Phase 3)Active Not RecruitingNCT06892288
What this trial is testing

Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG

Who this might be right for
Phosphomannomutase 2 DeficiencyPMM2-CDG
Glycomine, Inc. 50
Early research (Phase 1)Looking for participantsNCT07572825
What this trial is testing

Assessing the Safety and Tolerability of NMN in DHDDS-CDG

Who this might be right for
DHDDS-Congenital Disorder of GlycosylationDHDDS-CDGCongenital Disorder of Glycosylation
Eva Morava-Kozicz 8
Not applicableStudy completedNCT02955264
What this trial is testing

Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation

Who this might be right for
Congenital Disorders of Glycosylation
Tulane University 8
Large-scale testing (Phase 3)Ended earlyNCT04925960
What this trial is testing

Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG

Who this might be right for
Pmm2-CDGPhosphomannomutase 2 DeficiencyPhosphomannomutase 2 Congenital Disorder of Glycosylation+2 more
Maggie's Pearl, LLC 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05402384
What this trial is testing

AVTX-801 D-galactose Supplementation in SLC35A2-CDG

Who this might be right for
SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation
Eva Morava-Kozicz 10
Next Page